5 Materials Stocks That Are Flying – And May Collapse
The most overbought stocks in the materials sector presents an opportunity to go short on these overvalued companies.
Cano Health, Vacasa, Organogenesis, And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded higher, with the Nasdaq surging more than 500 points on Thursday. Here are some big stocks recording losses in today’s session.
Milliken And PureCycle Advance Circularity By Launching New Concentrate Using Recycled PP Resin
Release of first fully sustainable, odorless concentrate for polypropylene (PP) based on a recycled resin carrier
Dedicated to developing a "no-compromise" solution that promises high quality and no
PureCycle Technologies And SK Geo Centric Invest In Building First Polypropylene Recycling Plant In Asia
SKGC and PureCycle signed an agreement to create a joint venture on October, 20 2022. The signing ceremony was attended by Na Kyung-soo, CEO of SKGC, and Dustin Olson, CEO of PureCycle
With 50/50 ownership,
Marathon Digital, Coinbase Global And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session
U.S. stock futures traded higher this morning after recording losses in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
Gainers
9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.
Read How PureCycle Technologies Performed In Q2
PureCycle Technologies Inc (NASDAQ:PCT) reported a second-quarter net loss per share of $(0.09), the same as a year ago. Net…
PureCycle Technologies: Q2 Earnings Insights
PureCycle Technologies (NASDAQ:PCT) reported its Q2 earnings results on Friday, August 12, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 12, 2022
Companies Reporting Before The Bell
• NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million.
